Top Markets
#1 Derive Derive +30.46%
#2 Cross Cross +14.21%
#3 Audiera Audiera +13.22%
#4 The Bitcoin Bull The Bitcoin Bull +10.65%
#5 Geodnet Geodnet +9.21%
#6 Gama Token Gama Token +9.19%
#7 Velvet Velvet +8.25%
#8 Biconomy Biconomy +8.17%
#9 Fake World Assets Fake World Assets +8.05%
#10 Palladium Network Palladium Network +7.97%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Rank in Stocks #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Share Price
$0.46
Last synced: 2026-07-31
Market Cap
$3.42M
Change (1 day)
3.60%
Change (1 year)
-34.54%
Country
US
Trade Pasithea Therapeutics Corp. (KTTA)

Category

Healthcare
Stock price history for Pasithea Therapeutics Corp. (KTTA)
Highest end of day price: $0.48 on 2026-07-01

Lowest end of day price: $60.62 on 2021-09-01
Stock price history of Pasithea Therapeutics Corp. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -33.96%
2025 -58.48%
2024 -61.05%
2023 -55.07%
2022 -63.23%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE